I Moodley1, N Tathiah, V Mubaiwa, L Denny. 1. Department of Public Health Medicine, University of KwaZulu-Natal, Durban, South Africa. moodleyi15@ukzn.ac.za
Abstract
BACKGROUND: Cervical cancer is linked to infection of the cervix by oncogenic human papillomavirus (HPV) subtypes. The quadrivalent Gardasil vaccine (against HPV types 6, 11, 16, 18), recommended in girls 9 - 12 years of age, has been shown to be safe, immunogenic and efficacious, with minimal or no side-effects. AIM: To demonstrate the capacity of school health teams to carry out vaccinations within a school environment. OBJECTIVES: To assess the uptake of 3 doses of the vaccine, document lessons learnt and provide recommendations for a national rollout of school-based HPV vaccination for learners. METHODS: Female learners (age 9 - 12 years) from 31 primary schools in Nongoma and Ceza districts (KwaZulu-Natal province, South Africa) were identified for inclusion in the vaccination programme. The 3 doses of vaccine were administered by existing school health teams. Education and training sessions were held with all stakeholders: provincial departments of health and education; school health teams; primary healthcare nurses; hospital doctors and nurses; private practitioners; school principals, teachers and governing bodies; parents; and community and traditional leaders. RESULTS: The overall uptake of the vaccine was found to be high: 99.7%, 97.9% and 97.8% for the first, second and third doses respectively (N = 963). No adverse events were attributed to the HPV vaccine. CONCLUSION: This project demonstrated the successful implementation of HPV vaccination among learners (ages 9 - 12 years) using school health teams.
BACKGROUND: Cervical cancer is linked to infection of the cervix by oncogenic human papillomavirus (HPV) subtypes. The quadrivalent Gardasil vaccine (against HPV types 6, 11, 16, 18), recommended in girls 9 - 12 years of age, has been shown to be safe, immunogenic and efficacious, with minimal or no side-effects. AIM: To demonstrate the capacity of school health teams to carry out vaccinations within a school environment. OBJECTIVES: To assess the uptake of 3 doses of the vaccine, document lessons learnt and provide recommendations for a national rollout of school-based HPV vaccination for learners. METHODS: Female learners (age 9 - 12 years) from 31 primary schools in Nongoma and Ceza districts (KwaZulu-Natal province, South Africa) were identified for inclusion in the vaccination programme. The 3 doses of vaccine were administered by existing school health teams. Education and training sessions were held with all stakeholders: provincial departments of health and education; school health teams; primary healthcare nurses; hospital doctors and nurses; private practitioners; school principals, teachers and governing bodies; parents; and community and traditional leaders. RESULTS: The overall uptake of the vaccine was found to be high: 99.7%, 97.9% and 97.8% for the first, second and third doses respectively (N = 963). No adverse events were attributed to the HPV vaccine. CONCLUSION: This project demonstrated the successful implementation of HPV vaccination among learners (ages 9 - 12 years) using school health teams.
Authors: David C Griffith; David Adler; Melissa Wallace; Thola Bennie; Beau Abar; Linda-Gail Bekker Journal: J Womens Health Issues Care Date: 2015-09-23
Authors: Daniel N A Ankrah; Delese M Darko; George Sabblah; Aukje Mantel-Teeuwisse; Hubert M G Leufkens Journal: Hum Vaccin Immunother Date: 2017-11-27 Impact factor: 3.452
Authors: Stacey Perlman; Richard G Wamai; Paul A Bain; Thomas Welty; Edith Welty; Javier Gordon Ogembo Journal: PLoS One Date: 2014-03-11 Impact factor: 3.240
Authors: Joël Ladner; Marie-Hélène Besson; Mariana Rodrigues; Etienne Audureau; Joseph Saba Journal: BMC Public Health Date: 2014-06-30 Impact factor: 3.295
Authors: Moses Muia Masika; Javier Gordon Ogembo; Sophie Vusha Chabeda; Richard G Wamai; Nelly Mugo Journal: PLoS One Date: 2015-08-12 Impact factor: 3.240